A urine test strip that could transform kidney diet care?
NCT ID NCT07746037
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This trial is testing whether a connected urine test strip device, called URIKI, can help people with stage 4 or 5 chronic kidney disease monitor their diet from home. Participants will use the device daily for 10 days, logging meals and other health information in a mobile app. The goal is to see if this approach can make dietitian consultations more efficient and improve nutritional care for people with advanced kidney disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- URIKI Digital Urinary Monitoring System (connected urine test strips, portable reader, mobile app, and healthcare platform)
- What this could lead to
- If effective, this device could make it easier for people with advanced kidney disease to track their diet at home and help dietitians provide more efficient, personalized nutritional care.
- What could go wrong
- This is an early-stage study focused on feasibility and workflow, not on health outcomes. The device may not prove accurate or practical for daily use, and results may not apply beyond the study setting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 450 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 years or older. * Chronic kidney disease (CKD) stage 4 or 5 with estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73 m². * Followed in a nephrology department within a structured care pathway that includes nutritional assessment. * Clinical indication or need for nutritional assessment as part of routine care. * Willing and able to use the URIKI device for nutritional assessment. * Able to understand French or English, or assisted by a caregiver capable of supporting device use and understanding study procedures. * Agreement to the use of the device and to the collection and transmission of study-related data. * Affiliation with a social security system or beneficiary of such coverage. * Access to a compatible smartphone, a smartphone provided by IKI, or assistance from a caregiver for use of the mobile application Exclusion Criteria: * Pregnant or breastfeeding women. * Severe cognitive impairment preventing understanding of study procedures or use of the application without caregiver assistance. * Major motor or sensory impairments (e.g., blindness, hemiplegia) preventing use of the device without caregiver assistance. * Inability to understand French or English without support from a caregiver or third party. * Refusal of the loaned smartphone or persistent inability to use the provided equipment despite support. * Refusal to participate in the study or withdrawal after receiving study information. * Concurrent participation in another interventional clinical study deemed incompatible with this study, or an ongoing exclusion period related to another study. * Individuals under legal protection (guardianship or curatorship), unless participation is authorized by the legal representative and ethics committee
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney disease (CKD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hôpital Pitié-Salpêtrière - APHP, Département de Néphrologie, Néphrologie Ambulatoire et Onco-Néphrologie
Paris, France
-
Hôpital Tenon - APHP, Département de Néphrologie, Néphrologie Ambulatoire et Onco-Néphrologie
Paris, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Higher domperidone doses under scrutiny for older kidney patients
- Does dialysis strip the body of essential metals?
- Which dialysis method offers the best life and survival?
- Can big data unmask hidden clusters of cardiometabolic disease?
- Plastics in dialysis: could they add toxins to Children's blood?
- Can a newer heart failure drug protect kidneys better than an older one?